April 12, 2023
“”We’re are proud to be among the Finalists of the 2023 >>venture>> Finalists! Venture.ch is a highly competitve challenge for startups and selects highly promising start-ups.” said Luc Otten Chief Executive Officer of TheraPPI Bioscience (“TheraPPI”), a preclinical biotechnology company developing a portfolio of small molecules modifying protein interactions in oncology, rare diseases and inflammation.
…
Read in LinkedIn > https://www.linkedin.com/feed/update/urn:li:activity:7051825592316358657/